Analyst Round-Up Intel (INTC): 25 Analysts Play Catch-Up (Raise Price Targets)
Get Alerts INTC Hot Sheet
Price: $103.12 -6.12%
Rating Summary:
24 Buy, 39 Hold, 4 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 16 | Down: 7 | New: 60
Rating Summary:
24 Buy, 39 Hold, 4 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 16 | Down: 7 | New: 60
Join SI Premium – FREE
As expected, almost every firm on the Street with a research branch has issued a report on Intel (Nasdaq: INTC) today following its Q3 earnings report. While analysts seem to be staying pat on their investment ratings, most are adjusting their estimates and price targets accordingly.
Below is a summary of the analyst action on shares of Intel:
Now the real question to ask... is it a good or bad thing that all these analysts are jumping on the bandwagon?
Below is a summary of the analyst action on shares of Intel:
- Goldman Sachs - maintains Neutral, price target raised from $16 to $17
- Morgan Stanley - maintains Overweight, price target raised from $24 to $25
- Deutsche Bank - maintains Buy, price target raised from $24 to $25
- BofA Merrill Lynch - maintains Buy, price target raised from $25 to $27
- Barclays - maintains Equalweight, price target raised from $22 to $24
- Citi - maintains Buy, price target raised from $25 to $26
- UBS - maintains Buy, price target raised from $24 to $27
- Credit Suisse - maintains Outperform, price target raised from $24 to $27
- Piper Jaffray - maintains Overweight, price target raised from $21 to $26
- Oppenheimer - maintains Outperform, sets price target of $28
- FBR Capital - maintains Market Perform, price target raised from $23 to $27
- Wedbush - maintains Outperform, price target raised from $25 to $26
- Bernstein - maintains Market Perform, price target raised from $19.50 to $21.50
- Needham - maintains Buy, price target raised from $24 to $28
- Jefferies - maintains Underperform, price target raised from $14 to $15
- Roth Capital - maintains Buy, price target raised from $25 to Street high $33
- Auriga - maintains Sell, price target raised from $16 to $17
- Calyon - maintains Underperform, price target raised from $20 to $23
- Broadpoint.AmTech - maintains Buy, price target raised from $25 to $29
- JMP Securities - maintains Outperform, price target raised from $24 to $28
- Davenport - maintains Buy, raises price target from $27 to $29
- Miller Tabak - maintains Buy, price target raised from $22 to $25
- Canaccord Adams - maintains Buy, price target raised from $20 to $25
- FTN Equity - maintains Buy, price target raised from $23 to $25
- GC Research - maintains Neutral, price target raised from $21 to $24
Now the real question to ask... is it a good or bad thing that all these analysts are jumping on the bandwagon?
You May Also Be Interested In
- Erasca prices upsized stock offering at $17.50 per share
- Erasca proposes $500M common stock public offering
- UBS Upgrades IMCD NV (IMCD:NA) to Buy
Create E-mail Alert Related Categories
Analyst Comments, Insiders' Blog, Trader TalkRelated Entities
Credit Suisse, Piper Jaffray, Deutsche Bank, UBS, Citi, Morgan Stanley, Jefferies & Co, Davenport, Canaccord Adams, Calyon Securities, Needham & Company, Roth Capital, American Technology Research, JMP Securities, Barclays, EIM GroupSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share